Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ChargePoint Holdings, Inc. stock logo
CHPT
ChargePoint
$9.03
-3.6%
$6.10
$4.44
$12.61
$220.35M1.77907,598 shs1.56 million shs
NeoVolta, Inc. stock logo
NEOV
NeoVolta
$3.98
+1.4%
$2.88
$1.36
$7.13
$224.73M-0.871.56 million shs844,053 shs
Lixte Biotechnology Holdings, Inc. stock logo
NMAD
Lixte Biotechnology
$3.87
+0.3%
$6.34
$2.36
$8.38
$62.31M1.3197,152 shs35,707 shs
SES AI Corporation stock logo
SES
SES AI
$0.52
-8.5%
$0.61
$0.49
$3.73
$193.44M110.55 million shs14.72 million shs
The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ChargePoint Holdings, Inc. stock logo
CHPT
ChargePoint
-5.63%+77.53%+51.22%+47.15%-12.88%
NeoVolta, Inc. stock logo
NEOV
NeoVolta
+1.55%+7.40%+38.03%+102.06%+1.03%
Lixte Biotechnology Holdings, Inc. stock logo
NMAD
Lixte Biotechnology
-4.22%-5.85%-48.60%-43.98%-10.65%
SES AI Corporation stock logo
SES
SES AI
+12.25%+9.47%+1.60%-46.48%-51.90%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ChargePoint Holdings, Inc. stock logo
CHPT
ChargePoint
$9.03
-3.6%
$6.10
$4.44
$12.61
$220.35M1.77907,598 shs1.56 million shs
NeoVolta, Inc. stock logo
NEOV
NeoVolta
$3.98
+1.4%
$2.88
$1.36
$7.13
$224.73M-0.871.56 million shs844,053 shs
Lixte Biotechnology Holdings, Inc. stock logo
NMAD
Lixte Biotechnology
$3.87
+0.3%
$6.34
$2.36
$8.38
$62.31M1.3197,152 shs35,707 shs
SES AI Corporation stock logo
SES
SES AI
$0.52
-8.5%
$0.61
$0.49
$3.73
$193.44M110.55 million shs14.72 million shs
The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ChargePoint Holdings, Inc. stock logo
CHPT
ChargePoint
-5.63%+77.53%+51.22%+47.15%-12.88%
NeoVolta, Inc. stock logo
NEOV
NeoVolta
+1.55%+7.40%+38.03%+102.06%+1.03%
Lixte Biotechnology Holdings, Inc. stock logo
NMAD
Lixte Biotechnology
-4.22%-5.85%-48.60%-43.98%-10.65%
SES AI Corporation stock logo
SES
SES AI
+12.25%+9.47%+1.60%-46.48%-51.90%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ChargePoint Holdings, Inc. stock logo
CHPT
ChargePoint
1.73
Reduce$6.93-23.27% Downside
NeoVolta, Inc. stock logo
NEOV
NeoVolta
2.43
Hold$9.50138.99% Upside
Lixte Biotechnology Holdings, Inc. stock logo
NMAD
Lixte Biotechnology
1.00
SellN/AN/A
SES AI Corporation stock logo
SES
SES AI
2.00
Hold$2.55389.44% Upside

Current Analyst Ratings Breakdown

Latest NMAD, CHPT, NEOV, and SES Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/4/2026
ChargePoint Holdings, Inc. stock logo
CHPT
ChargePoint
Reiterated RatingNeutral
9/4/2026
ChargePoint Holdings, Inc. stock logo
CHPT
ChargePoint
Boost Price TargetNeutral$6.00 ➝ $8.00
9/3/2026
ChargePoint Holdings, Inc. stock logo
CHPT
ChargePoint
Reiterated RatingHold
9/3/2026
ChargePoint Holdings, Inc. stock logo
CHPT
ChargePoint
Reiterated RatingMarket Perform
9/3/2026
ChargePoint Holdings, Inc. stock logo
CHPT
ChargePoint
Reiterated RatingHold
9/1/2026
NeoVolta, Inc. stock logo
NEOV
NeoVolta
Reiterated RatingBuy
8/25/2026
SES AI Corporation stock logo
SES
SES AI
UpgradeSell (E+)Sell (D-)
8/14/2026
Lixte Biotechnology Holdings, Inc. stock logo
NMAD
Lixte Biotechnology
DowngradeSell (E+)Sell (E)
8/12/2026
SES AI Corporation stock logo
SES
SES AI
Set Price Target$1.10
8/11/2026
SES AI Corporation stock logo
SES
SES AI
DowngradeSell (D-)Sell (E+)
7/29/2026
NeoVolta, Inc. stock logo
NEOV
NeoVolta
Initiated CoverageOutperform
(Data available from 9/9/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ChargePoint Holdings, Inc. stock logo
CHPT
ChargePoint
$432.89M0.51N/AN/A$0.88 per share10.26
NeoVolta, Inc. stock logo
NEOV
NeoVolta
$18.07M12.45N/AN/A$0.09 per share44.17
Lixte Biotechnology Holdings, Inc. stock logo
NMAD
Lixte Biotechnology
N/AN/AN/AN/A$1.05 per shareN/A
SES AI Corporation stock logo
SES
SES AI
$23.46M8.24N/AN/A$0.59 per share0.88
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ChargePoint Holdings, Inc. stock logo
CHPT
ChargePoint
-$220.20M-$7.18N/AN/AN/A-40.59%-723.17%-15.49%N/A
NeoVolta, Inc. stock logo
NEOV
NeoVolta
-$5.03M-$0.33N/AN/AN/A-63.35%-141.89%-89.61%9/9/2026 (Estimated)
Lixte Biotechnology Holdings, Inc. stock logo
NMAD
Lixte Biotechnology
-$6.01M-$1.00N/AN/AN/AN/A-75.49%-62.03%N/A
SES AI Corporation stock logo
SES
SES AI
-$73.04M-$0.20N/AN/AN/A-289.64%-26.21%-20.78%11/11/2026 (Estimated)

Latest NMAD, CHPT, NEOV, and SES Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
10/5/2026Q4 2026
NeoVolta, Inc. stock logo
NEOV
NeoVolta
-$0.09N/AN/AN/A$1.27 millionN/A
9/9/2026Q4 2026
NeoVolta, Inc. stock logo
NEOV
NeoVolta
-$0.09N/AN/AN/A$1.27 millionN/A
9/2/2026Q2 2027
ChargePoint Holdings, Inc. stock logo
CHPT
ChargePoint
-$1.57-$1.35+$0.22-$1.35$105.21 million$116.08 million
8/11/2026Q2 2026
SES AI Corporation stock logo
SES
SES AI
-$0.0417-$0.04+$0.0017-$0.05$5.60 million$5.07 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
ChargePoint Holdings, Inc. stock logo
CHPT
ChargePoint
N/AN/AN/AN/AN/A
NeoVolta, Inc. stock logo
NEOV
NeoVolta
N/AN/AN/AN/AN/A
Lixte Biotechnology Holdings, Inc. stock logo
NMAD
Lixte Biotechnology
N/AN/AN/AN/AN/A
SES AI Corporation stock logo
SES
SES AI
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
ChargePoint Holdings, Inc. stock logo
CHPT
ChargePoint
10.73
1.15
0.56
NeoVolta, Inc. stock logo
NEOV
NeoVolta
N/A
8.10
7.30
Lixte Biotechnology Holdings, Inc. stock logo
NMAD
Lixte Biotechnology
N/A
12.87
12.87
SES AI Corporation stock logo
SES
SES AI
N/A
6.52
6.22

Institutional Ownership

CompanyInstitutional Ownership
ChargePoint Holdings, Inc. stock logo
CHPT
ChargePoint
37.77%
NeoVolta, Inc. stock logo
NEOV
NeoVolta
5.11%
Lixte Biotechnology Holdings, Inc. stock logo
NMAD
Lixte Biotechnology
5.10%
SES AI Corporation stock logo
SES
SES AI
29.78%

Insider Ownership

CompanyInsider Ownership
ChargePoint Holdings, Inc. stock logo
CHPT
ChargePoint
4.20%
NeoVolta, Inc. stock logo
NEOV
NeoVolta
4.00%
Lixte Biotechnology Holdings, Inc. stock logo
NMAD
Lixte Biotechnology
7.30%
SES AI Corporation stock logo
SES
SES AI
13.80%
CompanyEmployeesShares OutstandingFree FloatOptionable
ChargePoint Holdings, Inc. stock logo
CHPT
ChargePoint
1,44024.42 million23.39 millionOptionable
NeoVolta, Inc. stock logo
NEOV
NeoVolta
556.61 million54.34 millionNot Optionable
Lixte Biotechnology Holdings, Inc. stock logo
NMAD
Lixte Biotechnology
416.10 million14.93 millionNot Optionable
SES AI Corporation stock logo
SES
SES AI
130371.29 million320.05 millionOptionable

Recent News About These Companies

SES AI (NYSE:SES) Shares Up 0.2% - Here's Why
SES AI: The Selloff Has Changed The Risk-Reward Equation
SES AI faces NYSE delisting of public warrants
Stonegate Updates Coverage on SES AI Corp. (SES) 2Q26
SES AI Corporation (SES) Q2 2026 Earnings Call Transcript
SES AI Q2 Earnings Call Highlights
SES AI adds expert director to bolster ESS strategy

New MarketBeat Followers Over Time

Media Sentiment Over Time

ChargePoint stock logo

ChargePoint NYSE:CHPT

$9.03 -0.34 (-3.63%)
As of 01:30 PM Eastern
This is a fair market value price provided by Massive. Learn more.

ChargePoint Holdings, Inc., together with its subsidiaries, provides electric vehicle (EV) charging networks and charging solutions in the North America and Europe. The company serves commercial, such as retail, workplace, hospitality, parking, recreation, municipal, education, and highway fast charge; fleet, which include delivery, take home, logistics, motor pool, transit, and shared mobility; and residential including single family homes and multi-family apartments and condominiums customers. ChargePoint Holdings, Inc. was founded in 2007 and is headquartered in Campbell, California.

NeoVolta stock logo

NeoVolta NASDAQ:NEOV

$3.98 +0.06 (+1.40%)
As of 01:30 PM Eastern
This is a fair market value price provided by Massive. Learn more.

NeoVolta Inc. designs, manufactures, and sells energy storage systems in the United States. It provides NV14, NV14-K, and NV 24 energy storage systems, which stores and uses energy through batteries and an inverter at residential or commercial sites. The company markets and sells its products directly to certified solar installers and solar equipment distributors. NeoVolta Inc. was formed in 2018 and is headquartered in Poway, California.

Lixte Biotechnology stock logo

Lixte Biotechnology NASDAQ:NMAD

$3.87 +0.01 (+0.26%)
As of 01:09 PM Eastern

LIXTE Biotechnology Holdings, Inc., a clinical-stage pharmaceutical company, focuses on identifying targets for cancer drug development, and developing and commercializing cancer therapies. Its lead product candidate, LB-100 is in phase 1b clinical trials combined with Atezolizumab for patients with microsatellite stable metastatic colon cancer. The company's Phase 1b portion of its advanced soft tissue sarcoma clinical trial seeks to determine appropriate dosing and toxicity for treating soft tissue sarcomas with combination of LB-100 and standard-of-care chemotherapy; and LB-100 combined with dostarlimab that is in phase 1b/2 for ovarian clear cell carcinoma. The company has a clinical trial research agreement with the Netherlands Cancer Institute; collaboration agreement for an investigator-initiated clinical trial with the Spanish Sarcoma Group; and a development collaboration agreement with the Netherlands Cancer Institute. Lixte Biotechnology Holdings, Inc. was founded in 2005 and is based in Pasadena, California.

SES AI stock logo

SES AI NYSE:SES

$0.52 -0.05 (-8.52%)
As of 01:29 PM Eastern
This is a fair market value price provided by Massive. Learn more.

SES AI Corporation engages in the development and production of high-performance Lithium-metal rechargeable batteries for electric vehicles, electric vehicle take-off and landing, and other applications. The company was founded in 2012 and is headquartered in Woburn, Massachusetts.